Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jawed Polad

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of the American College of Cardiology|April 25, 2006
Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention in the drug-eluting stent era: an integrated clinical and angiographic analysis based on the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated At Rotterdam Cardiology Hospital (T-SEARCH) registriesMarco Valgimigli, Patrizia Malagutti, Gaston A Rodriguez-Granillo, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 27, 2020
Impact of coronary lesion complexity in percutaneous coronary intervention: one-year outcomes from the large, multicentre e-Ultimaster registryMohamed O Mohamed, Jawed Polad, David Hildick-Smith, et al.
Coronary Artery Disease|October 16, 2020
One-year performance of thin-strut cobalt chromium sirolimus-eluting stent versus thicker strut stainless steel biolimus-eluting coronary stent: a propensity-matched analysis of two international all-comers registriesSelina Vlieger, Gian B Danzi, Floris Kauer, et al.
The American Journal of Cardiology|September 14, 2023
Comparison of Supraflex Cruz 60 μm Versus Ultimaster Tansei 80 μm Stent Struts in High Bleeding Risk PCI Patients: Study design and Rational of Compare 60/80 HBR trialValeria Paradies, Matteo Maurina, Pim Tonino, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|July 25, 2022
Impact of multisite artery disease on clinical outcomes after percutaneous coronary intervention: an analysis from the e-Ultimaster registryOfer Kobo, Majdi Saada, Clemens von Birgelen, et al.
Heart (British Cardiac Society)|January 11, 2022
Outcomes and regional differences in practice in a worldwide coronary stent registryMurat Cimci, Jawed Polad, Mamas Mamas, et al.
Journal of Clinical Medicine|July 12, 2025
Efficacy and Safety of Low-Dose Rivaroxaban in High-Ischemic-Risk Patients with Chronic Coronary Syndrome: Rationale and Design of the DUTCH CCS RegistryAbi Selvarajah, Dirk J van der Heijden, Wouter S Remkes, et al.
JAMA|August 31, 2025
Fractional Flow Reserve-Guided Complete vs Culprit-Only Revascularization in Non-ST-Elevation Myocardial Infarction and Multivessel Disease: The SLIM Randomized Clinical TrialTobias F S Pustjens, Leo Veenstra, Cyril Camaro, et al.
Circulation. Cardiovascular Interventions|July 13, 2026
Abbreviated Dual Antiplatelet Therapy in Patients With High Bleeding Risk Undergoing PCI of Bifurcation Lesions: A Prespecified Substudy of the MASTER DAPT TrialBernard Chevalier, Davide Cao, Pieter C Smits, et al.
Atherosclerosis|February 27, 2021
Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trialElvin Kedhi, Monica Verdoia, Harry Suryapranata, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of the American College of Cardiology|April 25, 2006
Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention in the drug-eluting stent era: an integrated clinical and angiographic analysis based on the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated At Rotterdam Cardiology Hospital (T-SEARCH) registriesMarco Valgimigli, Patrizia Malagutti, Gaston A Rodriguez-Granillo, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 27, 2020
Impact of coronary lesion complexity in percutaneous coronary intervention: one-year outcomes from the large, multicentre e-Ultimaster registryMohamed O Mohamed, Jawed Polad, David Hildick-Smith, et al.
Coronary Artery Disease|October 16, 2020
One-year performance of thin-strut cobalt chromium sirolimus-eluting stent versus thicker strut stainless steel biolimus-eluting coronary stent: a propensity-matched analysis of two international all-comers registriesSelina Vlieger, Gian B Danzi, Floris Kauer, et al.
The American Journal of Cardiology|September 14, 2023
Comparison of Supraflex Cruz 60 μm Versus Ultimaster Tansei 80 μm Stent Struts in High Bleeding Risk PCI Patients: Study design and Rational of Compare 60/80 HBR trialValeria Paradies, Matteo Maurina, Pim Tonino, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|July 25, 2022
Impact of multisite artery disease on clinical outcomes after percutaneous coronary intervention: an analysis from the e-Ultimaster registryOfer Kobo, Majdi Saada, Clemens von Birgelen, et al.
Heart (British Cardiac Society)|January 11, 2022
Outcomes and regional differences in practice in a worldwide coronary stent registryMurat Cimci, Jawed Polad, Mamas Mamas, et al.
Journal of Clinical Medicine|July 12, 2025
Efficacy and Safety of Low-Dose Rivaroxaban in High-Ischemic-Risk Patients with Chronic Coronary Syndrome: Rationale and Design of the DUTCH CCS RegistryAbi Selvarajah, Dirk J van der Heijden, Wouter S Remkes, et al.
JAMA|August 31, 2025
Fractional Flow Reserve-Guided Complete vs Culprit-Only Revascularization in Non-ST-Elevation Myocardial Infarction and Multivessel Disease: The SLIM Randomized Clinical TrialTobias F S Pustjens, Leo Veenstra, Cyril Camaro, et al.
Circulation. Cardiovascular Interventions|July 13, 2026
Abbreviated Dual Antiplatelet Therapy in Patients With High Bleeding Risk Undergoing PCI of Bifurcation Lesions: A Prespecified Substudy of the MASTER DAPT TrialBernard Chevalier, Davide Cao, Pieter C Smits, et al.
Atherosclerosis|February 27, 2021
Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trialElvin Kedhi, Monica Verdoia, Harry Suryapranata, et al.
Pageof 3